Ketonuria with or without ketoacidosis as the presenting manifestation of SARS-CoV-2 (COVID-19) among uncontrolled type 2 diabetic patients

被引：4
作者：
Emara, Mohamed H. [1 ,2 ]
Mazid, Usama [2 ,3 ]
Atta, Mohammed Ali [4 ,5 ]
Elshahat, Sahar [6 ]
Mahros, Aya Mohammed [1 ,7 ]
机构：
[1] Kafrelshiekh Univ, Fac Med, Hepatol Gastroenterol & Infect Dis Dept, Kafr Elshiekh 33516, Egypt
[2] Alyousef Hosp, Dept Med, Al Khobar, Saudi Arabia
[3] Tanta Hosp Trop Dis, Tanta, Egypt
[4] Al Mahalla Gen Hosp, Dept Radiol, Almehala, Egypt
[5] Alyousef Hosp, Dept Radiol, Al Khobar, Saudi Arabia
[6] Al Azhar Univ, Alzahraa Hosp, Fac Med Girls, Dept Clin Pathol, Cairo, Egypt
[7] Alyousef Hosp, Dept Clin Pathol, Al Khobar, Saudi Arabia
来源：
MEDICAL HYPOTHESES | 2020年 / 144卷
关键词：
Kentonuria; SARS-CoV-2; COVID; Diabetes;
D O I：
10.1016/j.mehy.2020.110226
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
We present three diabetic patients cases presented with kentonuria as the presenting manifestation of SARS-CoV-2 infection.
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Characteristics and outcomes of diabetic patients infected by the SARS-CoV-2
    Elamari, Saloua
    Motaib, Imane
    Zbiri, Saad
    Elaidaoui, Karim
    Chadli, Asmaa
    Elkettani, Chafik
    PAN AFRICAN MEDICAL JOURNAL, 2020, 37 : 1 - 10
  • [22] Effect of Comorbid Diabetes on Clinical Characteristics of COVID-19 Patients Infected by the Wild-Type or Delta Variant of SARS-CoV-2
    Zhang, Jianguo
    Zhang, Jinhui
    Tao, Zhimin
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [23] Preprocedural Viral Load Effects of Oral Antiseptics on SARS-CoV-2 in Patients with COVID-19: A Systematic Review
    Ting, Miriam
    Dahlkemper, Alex
    Schwartz, Jeremy J.
    Woodfork, Manzel
    Suzuki, Jon B.
    BIOMEDICINES, 2023, 11 (06)
  • [24] Diabetic Ketoacidosis Precipitated by COVID-19 in Patients Without Respiratory Symptoms: Case Reports
    Meza, Jose L.
    Triana, Abel
    De Avila, Ivan
    Del Rio-Pertuz, Gaspar
    Viasus, Diego
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (08)
  • [25] Rate and Predictors of Hesitancy toward SARS-CoV-2 Vaccine among Type 2 Diabetic Patients: Results from an Italian Survey
    Guaraldi, Federica
    Montalti, Marco
    Di Valerio, Zeno
    Mannucci, Edoardo
    Nreu, Besmir
    Monami, Matteo
    Gori, Davide
    VACCINES, 2021, 9 (05)
  • [26] Therapy of Type 2 Diabetes in Patients with SARS-CoV-2 Infection
    Bielka, Weronika
    Przezak, Agnieszka
    Pawlik, Andrzej
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (14)
  • [27] Detecting SARS-CoV-2 RNA in conjunctival secretions: Is it a valuable diagnostic method of COVID-19?
    Guemes-Villahoz, Noemi
    Burgos-Blasco, Barbara
    Arribi-Vilela, Ana
    Arriola-Villalobos, Pedro
    Rico-Luna, Carla M.
    Cuina-Sardina, Ricardo
    Delgado-Iribarren, Alberto
    Garcia-Feijoo, Julian
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (01) : 383 - 388
  • [28] Tempering Macrophage Plasticity for Controlling SARS-CoV-2 Infection for Managing COVID-19 Disease
    Toor, Devinder
    Jain, Aklank
    Kalhan, Shivani
    Manocha, Harmesh
    Sharma, Vivek Kumar
    Jain, Payal
    Tripathi, Vishwas
    Prakash, Hridayesh
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [29] Effect of COVID-19 on the clinical course of diabetic ketoacidosis (DKA) in people with type 1 and type 2 diabetes
    Kempegowda, Punith
    Melson, Eka
    Johnson, Agnes
    Wallett, Lucy
    Thomas, Lucretia
    Zhou, Dengyi
    Holmes, Catherine
    Juszczak, Agata
    Karamat, Mohammed Ali
    Ghosh, Sandip
    Hanif, Wasim
    Narendran, Parth
    Bellary, Srikanth
    ENDOCRINE CONNECTIONS, 2021, 10 (04) : 371 - 377
  • [30] Diabetes and SARS-CoV-2 Infection: The Potential Role of Antidiabetic Therapy in the Evolution of COVID-19
    Pinchera, Biagio
    Schiano Moriello, Nicola
    Buonomo, Antonio Riccardo
    Di Filippo, Isabella
    Tanzillo, Anastasia
    Buzzo, Giorgio
    Villari, Riccardo
    Gentile, Ivan
    MICROORGANISMS, 2023, 11 (01)
12345